Skip to content

FIRST TRUST ADVISORS LP: CRWV position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of FIRST TRUST ADVISORS LP on CRWV, newest first. How the timeline and the estimate are built.

FIRST TRUST ADVISORS LP held 2,728,784 CRWV shares at 2026-06-30 per its 13F-HR filed 2026-08-11.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 2,728,784 shares
    Change vs previous 13F +984,787 shares

    0.16% of the 13F portfolio, value $271,623,159.

    13F-HR 0001445546-26-005965 filed by FIRST TRUST ADVISORS LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 1,743,997 shares
    Change vs previous 13F -541,996 shares

    0.1% of the 13F portfolio, value $135,107,447.

    13F-HR 0001445546-26-003611 filed by FIRST TRUST ADVISORS LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 2,285,993 shares
    Change vs previous 13F +341,645 shares

    0.12% of the 13F portfolio, value $163,699,958.

    13F-HR 0001445546-26-001219 filed by FIRST TRUST ADVISORS LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 1,944,348 shares
    Change vs previous 13F +1,820,101 shares

    0.2% of the 13F portfolio, value $266,084,023.

    13F-HR 0001445546-25-007494 filed by FIRST TRUST ADVISORS LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 124,247 shares
    Change vs previous 13F not available

    0.02% of the 13F portfolio, value $20,259,715.

    13F-HR 0001445546-25-005500 filed by FIRST TRUST ADVISORS LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).